Zacks Investment Research on MSN
SLN stock skyrockets 107% in six months: Here's what you need to know
Shares of Silence Therapeutics SLN have surged 107% over the past six months, driven by investor optimism around the ...
Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 7.2% in the last trading session to close at $10.45. The move was ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a prospective, multicenter study in Dermatology ...
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results